Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Carcinoid Tumor × Octreotide × Clear all

Phase

Phase 3 2 Phase 2 2 Phase 4 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Neuroendocrine Tumors 4 Neoplasms 2 Acromegaly 2 Serotonin Syndrome 1 Pituitary Neoplasms 1 Pancreatitis 1 Pancreatic Intraductal Neoplasms 1 Gastro-enteropancreatic neuroendocrine tumor 1 Fistula 1 Duodenal Neoplasms 1 Diarrhea 1 Colorectal Neoplasms 1 Carcinoid Tumor 1 Breast Neoplasms 1 Brain Neoplasms 1 Adenoma 1

Interventions

arginyllysine 1 Octreotide 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789281 2021-06-11

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

Novartis

Phase 4 Completed

34 enrolled 8 charts

Carcinoid Tumor, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡